{"input_url":"https://www.npr.org/transcripts/nx-s1-5913381","gnews_decode":"https://www.npr.org/transcripts/nx-s1-5913381","http_status":200,"final_url":"https://www.npr.org/transcripts/nx-s1-5913381","html_length":133806,"trafilatura_result":"ok","text_length":4621,"text_preview":"AILSA CHANG, HOST:\nPeptides have been getting a lot of buzz lately. Last month, the popular and experimental drugs were the topic of a marathon meeting held by the Food and Drug Administration. A panel of advisers supported easier access to half a dozen of these compounds, which are heavily promoted","verdict":"OK"}